Immunome, Inc. (IMNM)
19.35
+0.04
(+0.21%)
USD |
NASDAQ |
Oct 07, 12:40
Immunome 1 Year Total Returns (Daily) : 34.00% for Oct. 6, 2026
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| October 06, 2026 | 34.00% |
| October 05, 2026 | 71.00% |
| October 02, 2026 | 82.21% |
| October 01, 2026 | 84.22% |
| September 30, 2026 | 83.69% |
| September 29, 2026 | 93.03% |
| September 28, 2026 | 87.06% |
| September 25, 2026 | 110.8% |
| September 24, 2026 | 99.46% |
| September 23, 2026 | 129.5% |
| September 22, 2026 | 163.6% |
| September 21, 2026 | 167.0% |
| September 18, 2026 | 143.4% |
| September 17, 2026 | 166.2% |
| September 16, 2026 | 158.1% |
| September 15, 2026 | 152.6% |
| September 14, 2026 | 166.6% |
| September 11, 2026 | 154.9% |
| September 10, 2026 | 177.4% |
| September 09, 2026 | 183.6% |
| September 08, 2026 | 185.2% |
| September 04, 2026 | 173.1% |
| September 03, 2026 | 165.0% |
| September 02, 2026 | 194.5% |
| September 01, 2026 | 184.6% |
| Date | Value |
|---|---|
| August 31, 2026 | 188.2% |
| August 28, 2026 | 178.5% |
| August 27, 2026 | 190.2% |
| August 26, 2026 | 183.0% |
| August 25, 2026 | 196.2% |
| August 24, 2026 | 171.9% |
| August 21, 2026 | 186.6% |
| August 20, 2026 | 193.4% |
| August 19, 2026 | 197.7% |
| August 18, 2026 | 168.9% |
| August 17, 2026 | 166.5% |
| August 14, 2026 | 173.6% |
| August 13, 2026 | 163.9% |
| August 12, 2026 | 182.4% |
| August 11, 2026 | 171.7% |
| August 10, 2026 | 165.1% |
| August 07, 2026 | 153.6% |
| August 06, 2026 | 146.8% |
| August 05, 2026 | 135.2% |
| August 04, 2026 | 128.9% |
| August 03, 2026 | 117.3% |
| July 31, 2026 | 116.3% |
| July 30, 2026 | 114.7% |
| July 29, 2026 | 118.0% |
| July 28, 2026 | 114.2% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
1 Year Total Returns (Daily) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 64.11% |
| Erasca, Inc. | 513.7% |
| Oncolytics Biotech, Inc. | -56.03% |
| Sangamo Therapeutics, Inc. | -79.97% |
| Sarepta Therapeutics, Inc. | -25.58% |